ACRS logo

Aclaris Therapeutics (ACRS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$39.88 M
-$5.40 M-11.92%

December 31, 2023


Summary


Performance

ACRS Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRSbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$47.65 M
+$24.82 M+108.68%

September 30, 2024


Summary


Performance

ACRS Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRSbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ACRS Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.9%+22.1%
3 y3 years+80.8%-11.1%
5 y5 years-30.1%+59.4%

ACRS Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-11.9%+45.8%-30.2%+108.7%
5 y5-year-11.9%+80.8%-58.0%+116.0%
alltimeall time-30.1%+315.9%-58.0%+383.7%

Aclaris Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$47.65 M(+108.7%)
Jun 2024
-
$22.83 M(-36.3%)
Mar 2024
-
$35.84 M(-10.1%)
Dec 2023
$39.88 M(-11.9%)
$39.88 M(+2.1%)
Sep 2023
-
$39.04 M(+25.3%)
Jun 2023
-
$31.15 M(-30.3%)
Mar 2023
-
$44.72 M(-1.2%)
Dec 2022
$45.28 M(+65.6%)
$45.28 M(-26.6%)
Sep 2022
-
$61.65 M(-9.7%)
Jun 2022
-
$68.26 M(+87.8%)
Mar 2022
-
$36.34 M(+32.9%)
Dec 2021
$27.35 M(+24.0%)
$27.35 M(-49.0%)
Sep 2021
-
$53.60 M(-52.8%)
Jun 2021
-
$113.45 M(+221.7%)
Mar 2021
-
$35.27 M(+59.8%)
Dec 2020
$22.06 M(-35.5%)
$22.06 M(-6.7%)
Sep 2020
-
$23.64 M(-27.4%)
Jun 2020
-
$32.59 M(-39.6%)
Mar 2020
-
$53.99 M(+57.9%)
Dec 2019
$34.19 M
$34.19 M(+14.3%)
DateAnnualQuarterly
Sep 2019
-
$29.90 M(-5.5%)
Jun 2019
-
$31.65 M(-7.4%)
Mar 2019
-
$34.20 M(-40.0%)
Dec 2018
$57.02 M(+182.2%)
$57.02 M(+114.4%)
Sep 2018
-
$26.59 M(-42.2%)
Jun 2018
-
$46.03 M(-16.1%)
Mar 2018
-
$54.88 M(+171.7%)
Dec 2017
$20.20 M(-33.0%)
$20.20 M(-66.4%)
Sep 2017
-
$60.05 M(+83.6%)
Jun 2017
-
$32.71 M(+38.1%)
Mar 2017
-
$23.68 M(-21.5%)
Dec 2016
$30.17 M(+206.3%)
$30.17 M(+69.5%)
Sep 2016
-
$17.80 M(-44.1%)
Jun 2016
-
$31.82 M(+142.3%)
Mar 2016
-
$13.13 M(+33.3%)
Dec 2015
$9.85 M(-8.4%)
$9.85 M(-61.2%)
Sep 2015
-
$25.42 M(+158.0%)
Jun 2015
-
$9.85 M(-8.4%)
Dec 2014
$10.76 M(+12.2%)
$10.76 M
Dec 2013
$9.59 M
-

FAQ

  • What is Aclaris Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Aclaris Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Aclaris Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of ACRS is $39.88 M

What is the all time high annual cash & cash equivalents for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual cash & cash equivalents is $57.02 M

What is Aclaris Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, ACRS annual cash & cash equivalents has changed by -$5.40 M (-11.92%)

What is Aclaris Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ACRS is $47.65 M

What is the all time high quarterly cash and cash equivalents for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly cash and cash equivalents is $113.45 M

What is Aclaris Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, ACRS quarterly cash and cash equivalents has changed by +$8.61 M (+22.06%)